Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
The company's plan to restructure itself isn't sparking investor optimism.
Saturday, October 13, 2018
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
The company's plan to restructure itself isn't sparking investor optimism.
Related Posts:
How Amazon targeting unprofitable items is helping competitor Boxed- Oil dives on fears of glut, global economic slowdown
- Tech stocks help Wall Street rebound, financials rise ahead of Fed
- GM cutting 50 jobs at U.S. battery plant tied to Chevy Volt
- German auto supplier to plead guilty, pay $35 million fine in VW emissions case
0 comments:
Post a Comment